EMIT II PLUS MONOCLONAL COCAINE METABOLITE ASSAY
K-Number: K020441 · 2002-03-28
Advertisement
Device Summary
Frequently Asked Questions
What is the EMIT II PLUS MONOCLONAL COCAINE METABOLITE ASSAY?
EMIT II PLUS MONOCLONAL COCAINE METABOLITE ASSAY is a medical device that received FDA 510(k) clearance on 2002-03-28. The listed applicant is Dade Behring, Inc.. The 510(k) number is K020441.
When did EMIT II PLUS MONOCLONAL COCAINE METABOLITE ASSAY receive FDA 510(k) clearance?
EMIT II PLUS MONOCLONAL COCAINE METABOLITE ASSAY received FDA 510(k) clearance on 2002-03-28, under 510(k) number K020441.
Who is the listed applicant for EMIT II PLUS MONOCLONAL COCAINE METABOLITE ASSAY?
The FDA 510(k) record lists Dade Behring, Inc. as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for EMIT II PLUS MONOCLONAL COCAINE METABOLITE ASSAY?
The FDA product code for EMIT II PLUS MONOCLONAL COCAINE METABOLITE ASSAY is DIO.
Related Clinical Trials
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Other records listing Dade Behring, Inc. as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: DIO)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.
Advertisement